048sek
-0,4 %
Date:2025-07-14Time:16:12:29Latest report:Q1-2025List:First NorthTicker:TOL
Market Cap:130 msekEnterprise Value:124 msekNet Sales:- msekEarnings:-11,9 msekEmployees:0ISIN:SE0007438577

Ratios

10-year key figure history for Toleranzia turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Toleranzia with index and moving average MA50 and MA200.

Stockprice:0,48
MA50:0,46
MA200:0,50
Price/MA200:-4,2 %
RSI (14):56,8
Price/MA50:3,5 %

Description

Toleranzia is a research company. The company is active in the development of drug candidates for the treatment of autoimmune diseases. The company has developed a platform technology with a focus on the muscle disease myasthenia gravis. In addition, the technology has been used in other areas such as diabetes and multiple sclerosis. Research collaborations take place in collaboration with external partners within the work area. The headquarters are located in Gothenburg.

Medical Equipment